These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 12228884)

  • 1. Survival curve estimation with partial non-random exposure information.
    Brookmeyer R; Curriero FC
    Stat Med; 2002 Sep; 21(18):2671-83. PubMed ID: 12228884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E epsilon4 count affects age at onset of Alzheimer disease, but not lifetime susceptibility: The Cache County Study.
    Khachaturian AS; Corcoran CD; Mayer LS; Zandi PP; Breitner JC;
    Arch Gen Psychiatry; 2004 May; 61(5):518-24. PubMed ID: 15123497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein E genotype and mortality: findings from the Cache County Study.
    Hayden KM; Zandi PP; Lyketsos CG; Tschanz JT; Norton MC; Khachaturian AS; Pieper CF; Welsh-Bohmer KA; Breitner JC;
    J Am Geriatr Soc; 2005 Jun; 53(6):935-42. PubMed ID: 15935014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism of the regulatory region of the presenilin-2 gene in sporadic Alzheimer's disease: a case-control study.
    Quan W; Yasuda M; Hashimoto M; Yamamoto Y; Ishii K; Kazui H; Mori E; Kakigi T; Maeda K
    J Neurol Sci; 2006 Jan; 240(1-2):71-5. PubMed ID: 16233903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
    Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
    Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic association of ubiquilin with Alzheimer's disease and related quantitative measures.
    Kamboh MI; Minster RL; Feingold E; DeKosky ST
    Mol Psychiatry; 2006 Mar; 11(3):273-9. PubMed ID: 16302009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein Eepsilon4 modifies Alzheimer's disease onset in an E280A PS1 kindred.
    Pastor P; Roe CM; Villegas A; Bedoya G; Chakraverty S; García G; Tirado V; Norton J; Ríos S; Martínez M; Kosik KS; Lopera F; Goate AM
    Ann Neurol; 2003 Aug; 54(2):163-9. PubMed ID: 12891668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease.
    Hoyt BD; Massman PJ; Schatschneider C; Cooke N; Doody RS
    Arch Neurol; 2005 Mar; 62(3):454-9. PubMed ID: 15767511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Presence of an APOE4 allele results in significantly earlier onset of Parkinson's disease and a higher risk with dementia.
    Pankratz N; Byder L; Halter C; Rudolph A; Shults CW; Conneally PM; Foroud T; Nichols WC
    Mov Disord; 2006 Jan; 21(1):45-9. PubMed ID: 16116614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age at onset: an essential variable for the definition of genetic risk factors for sporadic Alzheimer's disease.
    Beyer K; Lao JI; Latorre P; Ariza A
    Ann N Y Acad Sci; 2005 Dec; 1057():260-78. PubMed ID: 16399900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Context-specific memory and apolipoprotein E (ApoE) epsilon 4: cognitive evidence from the NIMH prospective study of risk for Alzheimer's disease.
    Levy JA; Bergeson J; Putnam K; Rosen V; Cohen R; Lalonde F; Mirza N; Linker G; Sunderland T
    J Int Neuropsychol Soc; 2004 May; 10(3):362-70. PubMed ID: 15147594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease.
    Lehmann DJ; Cortina-Borja M; Warden DR; Smith AD; Sleegers K; Prince JA; van Duijn CM; Kehoe PG
    Am J Epidemiol; 2005 Aug; 162(4):305-17. PubMed ID: 16033878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Missing data in the exposure of interest and marginal structural models: a simulation study based on the Framingham Heart Study.
    Shortreed SM; Forbes AB
    Stat Med; 2010 Feb; 29(4):431-43. PubMed ID: 20025082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Object naming and semantic fluency among individuals with genetic risk for Alzheimer's disease.
    Miller KJ; Rogers SA; Siddarth P; Small GW
    Int J Geriatr Psychiatry; 2005 Feb; 20(2):128-36. PubMed ID: 15660408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial clustering and genetic risk for dementia in a genetically isolated Dutch population.
    Sleegers K; Roks G; Theuns J; Aulchenko YS; Rademakers R; Cruts M; van Gool WA; Van Broeckhoven C; Heutink P; Oostra BA; van Swieten JC; van Duijn CM
    Brain; 2004 Jul; 127(Pt 7):1641-9. PubMed ID: 15130954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cyclooxygenase 2 -765 C promoter allele is a protective factor for Alzheimer's disease.
    Abdullah L; Ait-Ghezala G; Crawford F; Crowell TA; Barker WW; Duara R; Mullan M
    Neurosci Lett; 2006 Mar; 395(3):240-3. PubMed ID: 16309832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOE is associated with age-of-onset, but not cognitive functioning, in late-life depression.
    Butters MA; Sweet RA; Mulsant BH; Ilyas Kamboh M; Pollock BG; Begley AE; Reynolds CF; DeKosky ST
    Int J Geriatr Psychiatry; 2003 Dec; 18(12):1075-81. PubMed ID: 14677138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cerebrospinal fluid beta-amyloid1-42 and tau in control subjects at risk for Alzheimer's disease: the effect of APOE epsilon4 allele.
    Sunderland T; Mirza N; Putnam KT; Linker G; Bhupali D; Durham R; Soares H; Kimmel L; Friedman D; Bergeson J; Csako G; Levy JA; Bartko JJ; Cohen RM
    Biol Psychiatry; 2004 Nov; 56(9):670-6. PubMed ID: 15522251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk-reducing effect of education in Alzheimer's disease.
    Sando SB; Melquist S; Cannon A; Hutton M; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly J
    Int J Geriatr Psychiatry; 2008 Nov; 23(11):1156-62. PubMed ID: 18484674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chemokine receptor CCR5-Delta32 gene mutation is not protective against Alzheimer's disease.
    Combarros O; Infante J; Llorca J; Peña N; Fernández-Viadero C; Berciano J
    Neurosci Lett; 2004 Aug; 366(3):312-4. PubMed ID: 15288441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.